• Test Medical Cannabis Potency with Greater Accuracy Using New DEA-Exempted CBDA Certified Reference Material

Environmental Laboratory

Test Medical Cannabis Potency with Greater Accuracy Using New DEA-Exempted CBDA Certified Reference Material

Jan 16 2017

As part of our commitment to the emerging industry of medical cannabis analysis, Restek has expanded its selection of cannabinoid-related reference standards by adding cannabidiolic acid (CBDA). This 1,000 ppm standard is DEA-exempted, so there’s no need to purchase costly neat materials or to make your own standards, and it is prepared in acetonitrile, which helps maintain stability by preventing methylation of the carboxylic acid group on the molecule. Paired with Restek’s THC standards, it is perfect for the analysis of both neutrals and acids in cannabis products by LC and is a must for accurate quantification in medical cannabis potency testing and strain ID. Restek’s CBDA standard is also a certified reference material (CRM) so you know that it meets strict ISO quality requirements.

From potency to pesticides analysis, Restek offers the LC and GC chromatography columns, CRMs, accessories, and sample prep supplies—as well as technical literature and support—needed for accurate, reliable medical marijuana analysis. Learn more about Restek’s products and resources at www.restek.com/medical-cannabis and start growing your medical cannabis testing business today.


Digital Edition

AET 28.2 April/May 2024

May 2024

Business News - Teledyne Marine expands with the acquisition of Valeport - Signal partners with gas analysis experts in Korea Air Monitoring - Continuous Fine Particulate Emission Monitor...

View all digital editions

Events

The World Biogas Expo 2024

Jul 10 2024 Birmingham, UK

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

Australasian Waste & Recycling Expo

Jul 24 2024 Sydney, Australia

Chemical Indonesia

Jul 30 2024 Jakarta, Indonesia

China Energy Summit & Exhibition

Jul 31 2024 Beijing, China

View all events